NuVasive Financials
NUVADelisted Stock | USD 42.35 0.85 1.97% |
NuVasive |
Please note, the presentation of NuVasive's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NuVasive's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NuVasive's management manipulating its earnings.
NuVasive Stock Summary
NuVasive competes with Glaukos Corp, CONMED, LivaNova PLC, Masimo, and Orthopediatrics Corp. NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US6707041058 |
Business Address | 7475 Lusk Boulevard, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.nuvasive.com |
Phone | 858 909 1800 |
Currency | USD - US Dollar |
NuVasive Key Financial Ratios
Return On Equity | 0.0331 | |||
Return On Asset | 0.0242 | |||
Target Price | 44.0 | |||
Beta | 1.07 | |||
Z Score | 2.23 |
NuVasive Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuVasive's current stock value. Our valuation model uses many indicators to compare NuVasive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuVasive competition to find correlations between indicators driving NuVasive's intrinsic value. More Info.NuVasive is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NuVasive is roughly 1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuVasive's earnings, one of the primary drivers of an investment's value.NuVasive Market Pulse
Quote | 42.35 |
Change(%) | 1.97 |
Change | 0.85 |
Open | 43.2 |
Low | 42.24 |
High | 43.33 |
Volume | 0 |
Exchange | NASDAQ |
About NuVasive Financials
What exactly are NuVasive Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include NuVasive's income statement, its balance sheet, and the statement of cash flows. Potential NuVasive investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although NuVasive investors may use each financial statement separately, they are all related. The changes in NuVasive's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NuVasive's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.NuVasive Thematic Clasifications
NuVasive is part of several thematic ideas from Obamacare Repeal to Obamacare. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasNuVasive January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NuVasive help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NuVasive. We use our internally-developed statistical techniques to arrive at the intrinsic value of NuVasive based on widely used predictive technical indicators. In general, we focus on analyzing NuVasive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NuVasive's daily price indicators and compare them against related drivers.
Information Ratio | (0.03) | |||
Maximum Drawdown | 7.19 | |||
Value At Risk | (2.75) | |||
Potential Upside | 3.31 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |